Zepbound patient information pdf

Zepbound patient information pdf

Rating: 4.4 / 5 (4106 votes)

Downloads: 38526

CLICK HERE TO DOWNLOAD

.

.

.

.

.

.

.

.

.

.

ZEPBOUND contains tirzepatide and should not be used with other tirzepatide-containing products or any GLPreceptor agonist medicines. It is not known if ZEPBOUND is safe and effective when taken with other prescription, over-the-counter, or herbal Use Zepbound exactly as your healthcare provider says. Do not use the same site for each injection Use Zepboundtime each week, at any time of the day. Zepbound is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm. Change (rotate) your injection site with each weekly injection. For more information about the ZEPBOUND pen, visit our site at Gray Plunger • ZEPBOUND should be used with a reduced-calorie diet and increased physical activity. Get patients started on once-weekly Zepbound® (tirzepatide) and learn more about dosing and savings for your patients EPBOUNDTM What is it?ZEPBOUNDTM is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide(GLP-1) receptor agonist indicated to use Zepbound® is the brand name for a once-weekly injection called Tirzepatide, available inmg,mg andmg doses. The medication is approved for adults with a body mass This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your Test patients for antibodies to varicella zoster virus (VZV) before initiating ZEPOSIA; VZV vaccination of antibody-negative patients is recommended prior to commencing ,  · Tirzepatide (ZEPBOUND) injection, is available as a pre-filled, single-dose pen for injection that delivers doses of mg/ mL,mg/ mL, mg/ mL, tirzepatide (Zepbound) will be covered on the prescription drug benefit formonths when the following criteria are met: Patient has a prescription drug insurance benefit that For patients prescribed tirzepatide (MOUNJARO) for the management of typediabetes mellitus, please consult the tirzepatide (MOUNJARO) Criteria for Use. The tirzepatide Has the patient participated in a comprehensive weight management program that encourages behavioral modification, reduced calorie diet, and increased physical activity Saxenda Wegovy ZepboundHas the patient started treatment with the requested medication?Yes No IF NO, please answer questionsHas the patient taken the requested medication for less thanmonths?Yes No IF YES, please answer questionsDoes the patient have a previous Blue Cross NC approval and has taken the • If you have questions or problems with your ZEPBOUND pen, contact Lilly at Lilly-Rx () or call your healthcare provider.